Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

Alzheimer’s Disease—A Dysfunction in Cholesterol and Lipid Metabolism

By Lukiw Walter   Pappolla Miguel   Pelaez Ricardo   Bazan Nicolas  

Cellular and Molecular Neurobiology, Vol. 25, Iss. 3-4, 2005-06 ,pp. : 475-483

Springer Publishing Company

Access to resources Recommend Favorite

Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 253-258

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers for Alzheimer's Disease Diagnosis

By  

Current Alzheimer Research, Vol. 14, Iss. 11, 2017-10 ,pp. : 1149-1154

Bentham Science Publishers

Access to resources Recommend Favorite

F₂-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease

By Montine Thomas   Quinn Joseph   Kaye Jeffrey   Morrow Jason  

Journal of Molecular Neuroscience, Vol. 33, Iss. 1, 2007-09 ,pp. : 114-119

Humana Press, Inc

Access to resources Recommend Favorite